Front Row Advisors LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2023$1
-50.0%
2000.0%0.00%
-100.0%
Q4 2022$2
-100.0%
2000.0%0.00%
-50.0%
Q3 2022$4,000
-60.0%
2000.0%0.00%
-60.0%
Q2 2022$10,000
-33.3%
2000.0%0.01%
-16.7%
Q1 2022$15,000
-48.3%
2000.0%0.01%
-45.5%
Q4 2021$29,000
-29.3%
2000.0%0.01%
-35.3%
Q3 2021$41,000
-4.7%
2000.0%0.02%
-5.6%
Q2 2021$43,000
+19.4%
2000.0%0.02%
+5.9%
Q1 2021$36,000
+63.6%
2000.0%0.02%
+54.5%
Q4 2020$22,000
-12.0%
2000.0%0.01%
-15.4%
Q3 2020$25,0002000.01%
Other shareholders
NOVAVAX INC shareholders Q2 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders